Board of Directors
Prof. Justin Stebbing, Chairman
Justin is a clinical oncologist and has published over 500 peer-reviewed papers on cancer. He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists and sits on a number of advisory boards. He also has previous investment management experience as a healthcare analyst.
Josephine Dixon, Chair of the Audit Committee
Josephine is a chartered accountant who sits on the boards of Standard Life Equity Income Trust plc, JP Morgan European Investment Trust plc, Strategic Equity Capital plc and F&C Global Smaller Companies Trust plc. Her executive experience includes finance, governance and general commercial roles in a number of sectors.
Randeep Grewal, Chair of Management Engagement Committee
Randeep is a London-based fund manager at Trium, with over 17 years of Healthcare investment experience, including F&C Asset Management, ICAP Equities and Tudor. Randeep trained as a Vascular and General Surgeon and read both Medicine and Computer Science at Cambridge University. He sits on the board of Tissue Regenix.
Paul is a London-based managing partner at Eisenstat Capital Partners (ECAP), with 20 years’ investment experience. Before joining ECAP, he managed European equity portfolios at Fortress Investment Group. Prior to that, he was a portfolio manager at Deephaven Capital Management. He began his investment career as an analyst and assistant portfolio manager with UBS Asset Management.
Siddhartha is a cancer physician and professor at Columbia University. In addition to his extensive academic publications, he has written several books, including The Emperor of All Maladies (winner of a Pulitzer Prize in 2011). He is a Rhodes scholar and graduated from Stanford University, University of Oxford, and Harvard.